Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Relative to non-carriers of normal BMI, the joint effect of factor V Leiden and obesity led to a 7.9-fold increased risk (OR(adj) 7.86, 95% CI 4.70-13.15); for prothrombin 20210A this was a 6.6-fold increased risk (OR(adj) 6.58, 95% CI 2.31-18.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP528664.RAVOyfWLMnc0UJaz8ttVIJezbrxjBCFH5z0mwFUk2QJ8g130_assertion description "[Relative to non-carriers of normal BMI, the joint effect of factor V Leiden and obesity led to a 7.9-fold increased risk (OR(adj) 7.86, 95% CI 4.70-13.15); for prothrombin 20210A this was a 6.6-fold increased risk (OR(adj) 6.58, 95% CI 2.31-18.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528664.RAVOyfWLMnc0UJaz8ttVIJezbrxjBCFH5z0mwFUk2QJ8g130_provenance.
• NP87799.RA5v_jQ5dfw8PRmMXawz3c0QKZnua8117WE4izCCgT3Xw130_assertion description "[Relative to non-carriers of normal BMI, the joint effect of factor V Leiden and obesity led to a 7.9-fold increased risk (OR(adj) 7.86, 95% CI 4.70-13.15); for prothrombin 20210A this was a 6.6-fold increased risk (OR(adj) 6.58, 95% CI 2.31-18.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87799.RA5v_jQ5dfw8PRmMXawz3c0QKZnua8117WE4izCCgT3Xw130_provenance.
• NP87810.RAuf3dyXbeD0Q6plmafhxHpHnmuTOsI6ZTih8QyNtPMjc130_assertion description "[Relative to non-carriers of normal BMI, the joint effect of factor V Leiden and obesity led to a 7.9-fold increased risk (OR(adj) 7.86, 95% CI 4.70-13.15); for prothrombin 20210A this was a 6.6-fold increased risk (OR(adj) 6.58, 95% CI 2.31-18.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87810.RAuf3dyXbeD0Q6plmafhxHpHnmuTOsI6ZTih8QyNtPMjc130_provenance.
• NP678845.RASuXN_MBrfmc_J7Ci_ULadgo3NAjQgm5QSKcsGns9iSQ130_assertion description "[Relative to non-carriers of normal BMI, the joint effect of factor V Leiden and obesity led to a 7.9-fold increased risk (OR(adj) 7.86, 95% CI 4.70-13.15); for prothrombin 20210A this was a 6.6-fold increased risk (OR(adj) 6.58, 95% CI 2.31-18.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678845.RASuXN_MBrfmc_J7Ci_ULadgo3NAjQgm5QSKcsGns9iSQ130_provenance.
• assertion description "[Relative to non-carriers of normal BMI, the joint effect of factor V Leiden and obesity led to a 7.9-fold increased risk (OR(adj) 7.86, 95% CI 4.70-13.15); for prothrombin 20210A this was a 6.6-fold increased risk (OR(adj) 6.58, 95% CI 2.31-18.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Relative to non-carriers of normal BMI, the joint effect of factor V Leiden and obesity led to a 7.9-fold increased risk (OR(adj) 7.86, 95% CI 4.70-13.15); for prothrombin 20210A this was a 6.6-fold increased risk (OR(adj) 6.58, 95% CI 2.31-18.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Relative to non-carriers of normal BMI, the joint effect of factor V Leiden and obesity led to a 7.9-fold increased risk (OR(adj) 7.86, 95% CI 4.70-13.15); for prothrombin 20210A this was a 6.6-fold increased risk (OR(adj) 6.58, 95% CI 2.31-18.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Relative to non-carriers of normal BMI, the joint effect of factor V Leiden and obesity led to a 7.9-fold increased risk (OR(adj) 7.86, 95% CI 4.70-13.15); for prothrombin 20210A this was a 6.6-fold increased risk (OR(adj) 6.58, 95% CI 2.31-18.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP53142.RAQjz7AV5DcYWkmwzYWL2broSGQe4NBxrwOSUSInyQEVU130_assertion description "[Relative to non-carriers of normal BMI, the joint effect of factor V Leiden and obesity led to a 7.9-fold increased risk (OR(adj) 7.86, 95% CI 4.70-13.15); for prothrombin 20210A this was a 6.6-fold increased risk (OR(adj) 6.58, 95% CI 2.31-18.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP53142.RAQjz7AV5DcYWkmwzYWL2broSGQe4NBxrwOSUSInyQEVU130_provenance.
• NP112211.RAUCZkRDeY15kkfBA_JuPrydcUzUX-QDKf5Z0Tft5GOao130_assertion description "[Relative to non-carriers of normal BMI, the joint effect of factor V Leiden and obesity led to a 7.9-fold increased risk (OR(adj) 7.86, 95% CI 4.70-13.15); for prothrombin 20210A this was a 6.6-fold increased risk (OR(adj) 6.58, 95% CI 2.31-18.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP112211.RAUCZkRDeY15kkfBA_JuPrydcUzUX-QDKf5Z0Tft5GOao130_provenance.
• NP52944.RA7Q81ZwUPnsdv6vfcxC38I0jINtsswWuO7hbSl1axIaA130_assertion description "[Relative to non-carriers of normal BMI, the joint effect of factor V Leiden and obesity led to a 7.9-fold increased risk (OR(adj) 7.86, 95% CI 4.70-13.15); for prothrombin 20210A this was a 6.6-fold increased risk (OR(adj) 6.58, 95% CI 2.31-18.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP52944.RA7Q81ZwUPnsdv6vfcxC38I0jINtsswWuO7hbSl1axIaA130_provenance.
• NP391448.RAmWjlMJ7YlQNJLaiMxH6Hg-7i3KMPa9heDl-D85vVpFQ130_assertion description "[Relative to non-carriers of normal BMI, the joint effect of factor V Leiden and obesity led to a 7.9-fold increased risk (OR(adj) 7.86, 95% CI 4.70-13.15); for prothrombin 20210A this was a 6.6-fold increased risk (OR(adj) 6.58, 95% CI 2.31-18.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP391448.RAmWjlMJ7YlQNJLaiMxH6Hg-7i3KMPa9heDl-D85vVpFQ130_provenance.
• NP631988.RApEuzB1S6OHjog6pOPU9rg7wObvPdZbGWdB2mEeBmEjE130_assertion description "[Relative to non-carriers of normal BMI, the joint effect of factor V Leiden and obesity led to a 7.9-fold increased risk (OR(adj) 7.86, 95% CI 4.70-13.15); for prothrombin 20210A this was a 6.6-fold increased risk (OR(adj) 6.58, 95% CI 2.31-18.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP631988.RApEuzB1S6OHjog6pOPU9rg7wObvPdZbGWdB2mEeBmEjE130_provenance.
• NP389478.RA9LeiH8Y-UyB2Mp2NvTx-rkUByLKELcXYkTaYg7wHtUI130_assertion description "[Relative to non-carriers of normal BMI, the joint effect of factor V Leiden and obesity led to a 7.9-fold increased risk (OR(adj) 7.86, 95% CI 4.70-13.15); for prothrombin 20210A this was a 6.6-fold increased risk (OR(adj) 6.58, 95% CI 2.31-18.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389478.RA9LeiH8Y-UyB2Mp2NvTx-rkUByLKELcXYkTaYg7wHtUI130_provenance.
• NP631987.RALnEyVe5KSZyEdgz8nqowcj96u6ys8C9_1OA9v4NysKU130_assertion description "[Relative to non-carriers of normal BMI, the joint effect of factor V Leiden and obesity led to a 7.9-fold increased risk (OR(adj) 7.86, 95% CI 4.70-13.15); for prothrombin 20210A this was a 6.6-fold increased risk (OR(adj) 6.58, 95% CI 2.31-18.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP631987.RALnEyVe5KSZyEdgz8nqowcj96u6ys8C9_1OA9v4NysKU130_provenance.
• NP112210.RA2wFKNaGo9t2Da4M7CB4i_EsPMNgUVPraimZk83ZAFEY130_assertion description "[Relative to non-carriers of normal BMI, the joint effect of factor V Leiden and obesity led to a 7.9-fold increased risk (OR(adj) 7.86, 95% CI 4.70-13.15); for prothrombin 20210A this was a 6.6-fold increased risk (OR(adj) 6.58, 95% CI 2.31-18.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP112210.RA2wFKNaGo9t2Da4M7CB4i_EsPMNgUVPraimZk83ZAFEY130_provenance.